We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Aragon Pharmaceuticals Announces Acquisition by Johnson & Johnson

News   Jun 19, 2013

 
Aragon Pharmaceuticals Announces Acquisition by Johnson & Johnson
 
 
 

RELATED ARTICLES

A New Treatment For Elephantiasis?

News

Using RNA sequencing techniques, researchers have discovered that an experimental cancer drug could be used to treat a disabling parasitic disease.

READ MORE

Depression Affects a Third of Lung Cancer Patients

News

About one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depression, a new study suggests.

READ MORE

Permanent Hair Dye and Chemical Straighteners May Increase Breast Cancer Risk

News

Women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer compared with women who don't use these products, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE